Cornerstone Capital Management Holdings’s bluebird bio BLUE Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$3.04M	Buy	1,317 +16	+1%	+$32.5K	0.02%	623
2017 Q3	$2.31M	Sell	1,301 -85	-6%	-$119K	0.02%	684
2017 Q2	$1.89M	Buy	1,386 +11	+0.8%	+$13.3K	0.01%	744
2017 Q1	$1.62M	Buy	1,375 +727	+112%	+$742K	0.01%	795
2016 Q4	$517K	Buy	648 +46	+8%	+$36.5K	﹤0.01%	1084
2016 Q3	$528K	Buy	602 +355	+144%	+$257K	﹤0.01%	1062
2016 Q2	$139K	Sell	247 -147	-37%	-$83.3K	﹤0.01%	1247
2016 Q1	$217K	Sell	394 -493	-56%	-$303K	﹤0.01%	1194
2015 Q4	$738K	Sell	887 -219	-20%	-$219K	0.01%	962
2015 Q3	$1.23M	Buy	+1,106	New	+$2.02M	0.01%	834
2015 Q2	–	Sell	-1,282	Closed	-$2M	–	1416
2015 Q1	$2M	Buy	+1,282	New	+$1.69M	0.02%	721

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Cornerstone Capital Management Holdings's BLUE Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its bluebird bio (BLUE) stake by 1.2% in Q4 2017, buying an estimated $32.5K and bringing the position to 1,317 shares worth $3.04M. The position accounts for 0.02% of the portfolio, ranked #623.

Cornerstone Capital Management Holdings first reported a position in BLUE in Q1 2015 and has held it in 11 quarters since. 296 funds tracked by Wall St. Rank hold BLUE as of Q4 2017.

Cornerstone Capital Management Holdings held 1,317 shares of bluebird bio worth $3.04M as of Q4 2017.
Cornerstone Capital Management Holdings bought 16 bluebird bio shares in Q4 2017, an estimated $32.5K.
bluebird bio made up 0.02% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #623 holding.
Cornerstone Capital Management Holdings first reported a position in bluebird bio in Q1 2015 and has held it in 11 quarters since.
296 funds tracked by Wall St. Rank held bluebird bio as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.